MiR-429 Modulates the Expression of C-myc in Human Gastric Carcinoma Cells
Overview
Authors
Affiliations
Aim: MicroRNAs (miRNAs) are a recently discovered class of small non-coding RNAs that regulate gene expression and may contribute to the development and progression of many cancers. In this study, our goal was to investigate the regulation of miR-429 in gastric cancer and explored the mechanism/s by which it influenced pathogenesis of gastric cancer.
Methods: We used real-time reverse transcriptase-polymerase chain reaction to quantify the expression level of miR-429 in 52 gastric cancer tissues and their paracancerous tissues. Bioinformatics was used to predict downstream target genes of miR-429. SGC-7901 gastric cancer cells were transfected with miR-429 mimics and endogenous c-myc expression was detected by western blots. We performed functional assays using the 3'UTR of the c-myc gene as a miR-429 target in a luciferase reporter assay system.
Results: We showed that miR-429 was downregulated in human gastric carcinoma tissue and in SGC-7901 cells. Cell viability, proliferation and attachment were inhibited in miR-429-transfected cells. miR-429 significantly downregulated endogenous c-myc expression in SGC-7901 cells. Action of miR/429 on c-myc 3'UTR was confirmed. The levels of miR-429 in tumour tissue of patients with lymph node metastasis were significantly lower than in those without lymph node metastasis.
Conclusions: Our results suggested that miR-429 played a role in the pathogenesis of gastric carcinoma and may function as a recessive cancer gene. c-myc is an important miR-429 target gene.
Evidence to Support the Collaboration of SP1, MYC, and HIF1A and Their Association with microRNAs.
Chun J, Kimura K, Rajput M, Hsu M, Liang Y, Shanbhag A Curr Issues Mol Biol. 2024; 46(11):12481-12496.
PMID: 39590335 PMC: 11592871. DOI: 10.3390/cimb46110741.
Gheidari F, Arefian E, Saadatpour F, Kabiri M, Seyedjafari E, Teimoori-Toolabi L Mol Biol Rep. 2022; 49(12):11855-11866.
PMID: 36219319 DOI: 10.1007/s11033-022-07903-2.
The role of miR-200 family in the regulation of hallmarks of cancer.
Klicka K, Grzywa T, Mielniczuk A, Klinke A, Wlodarski P Front Oncol. 2022; 12:965231.
PMID: 36158660 PMC: 9492973. DOI: 10.3389/fonc.2022.965231.
Cavallari I, Ciccarese F, Sharova E, Urso L, Raimondi V, Silic-Benussi M Cancers (Basel). 2021; 13(23).
PMID: 34884985 PMC: 8656820. DOI: 10.3390/cancers13235874.
Stasevich E, Murashko M, Zinevich L, Demin D, Schwartz A Biomedicines. 2021; 9(8).
PMID: 34440124 PMC: 8389562. DOI: 10.3390/biomedicines9080921.